Conclusions The present analysis expanded on the results of the SUSTAIN 3 and SUSTAIN 7 clinical trials, which showed that once-weekly semaglutide was more efficacious than exenatide ER and dulaglutide 0.75 mg and 1.5 mg at bringing patients to each of three clinically relevant endpoints covering glycemic control, hypoglycemia, and weight loss
This process is called muscle protein synthesis, and it requires a steady supply of dietary amino acids, particularly leucine
Our pharmacists can help with dosing, side effects, and what to expect
For others, it occurs specifically after meals, particularly large or fatty meals
Research supports its role in promoting fat oxidation and improving metabolic flexibility, offering a practical option for those pursuing meaningful body recomposition without injections
it is about building a foundation for long-term tolerance and ensuring you can stay on the medication comfortably enough to reach your goals